A New Bioartificial Liver Using Porcine Hepatocyte Spheroids in High-Cell-Density Suspension Perfusion Culture: In Vitro Performance in Synthesized Culture Medium and in 100% Human Plasma

A prototype of a bioartificial liver (BAL) based on suspension perfusion culture of porcine hepatocyte spheroids was developed at 150 ml scale. About 2% (4 × 10 9 cells) of whole human liver cells was immobilized. The cell density in the bioreactor was 2.7 × 10 7 cells/ml, which was almost comparabl...

Full description

Bibliographic Details
Main Authors: Yasuyuki Sakai, Katsutoshi Naruse, Ikuo Nagashima, Tetsuichiro Muto, Motoyuki Suzuki
Format: Article
Language:English
Published: SAGE Publishing 1999-09-01
Series:Cell Transplantation
Online Access:https://doi.org/10.1177/096368979900800508
id doaj-ec0ee9e28ab54ddbb89204a60cbc9fd0
record_format Article
spelling doaj-ec0ee9e28ab54ddbb89204a60cbc9fd02020-11-25T03:32:21ZengSAGE PublishingCell Transplantation0963-68971555-38921999-09-01810.1177/096368979900800508A New Bioartificial Liver Using Porcine Hepatocyte Spheroids in High-Cell-Density Suspension Perfusion Culture: In Vitro Performance in Synthesized Culture Medium and in 100% Human PlasmaYasuyuki Sakai0Katsutoshi Naruse1Ikuo Nagashima2Tetsuichiro Muto3Motoyuki Suzuki4Institute of Industrial Science, University of Tokyo, Tokyo 106-8558, JapanDepartment of Surgery, Unit of Artificial Organs and TransplantationDepartment of Surgery, Unit of Artificial Organs and TransplantationUnit of Tumor Surgery, Faculty of Medicine, University of Tokyo, Tokyo 113-0033, JapanInstitute of Industrial Science, University of Tokyo, Tokyo 106-8558, JapanA prototype of a bioartificial liver (BAL) based on suspension perfusion culture of porcine hepatocyte spheroids was developed at 150 ml scale. About 2% (4 × 10 9 cells) of whole human liver cells was immobilized. The cell density in the bioreactor was 2.7 × 10 7 cells/ml, which was almost comparable to that of presently developed packed-bed-type BALs. The bioreactor was perfused with culture medium while retaining spheroids. This was done using a rotating stainless filter (pore size 50 μm). In vitro 8-h perfusion experiments utilizing both synthesized culture medium and 100% human plasma demonstrated the spheroids in the bioreactor had almost the same functions on a unit/cell basis as those in small-scale rotational culture. This indicated that the functional deterioration often associated with scaling up had been minimized. Rapid spheroid aggregation and dysfunction in specific human plasma pool must be eliminated before clinical application, although this phenomenon seemed to be inherent to porcine hepatocyte-based BALs. This prototype shows promise in meeting present clinical demands by achieving maximal metabolic activities even in the short term.https://doi.org/10.1177/096368979900800508
collection DOAJ
language English
format Article
sources DOAJ
author Yasuyuki Sakai
Katsutoshi Naruse
Ikuo Nagashima
Tetsuichiro Muto
Motoyuki Suzuki
spellingShingle Yasuyuki Sakai
Katsutoshi Naruse
Ikuo Nagashima
Tetsuichiro Muto
Motoyuki Suzuki
A New Bioartificial Liver Using Porcine Hepatocyte Spheroids in High-Cell-Density Suspension Perfusion Culture: In Vitro Performance in Synthesized Culture Medium and in 100% Human Plasma
Cell Transplantation
author_facet Yasuyuki Sakai
Katsutoshi Naruse
Ikuo Nagashima
Tetsuichiro Muto
Motoyuki Suzuki
author_sort Yasuyuki Sakai
title A New Bioartificial Liver Using Porcine Hepatocyte Spheroids in High-Cell-Density Suspension Perfusion Culture: In Vitro Performance in Synthesized Culture Medium and in 100% Human Plasma
title_short A New Bioartificial Liver Using Porcine Hepatocyte Spheroids in High-Cell-Density Suspension Perfusion Culture: In Vitro Performance in Synthesized Culture Medium and in 100% Human Plasma
title_full A New Bioartificial Liver Using Porcine Hepatocyte Spheroids in High-Cell-Density Suspension Perfusion Culture: In Vitro Performance in Synthesized Culture Medium and in 100% Human Plasma
title_fullStr A New Bioartificial Liver Using Porcine Hepatocyte Spheroids in High-Cell-Density Suspension Perfusion Culture: In Vitro Performance in Synthesized Culture Medium and in 100% Human Plasma
title_full_unstemmed A New Bioartificial Liver Using Porcine Hepatocyte Spheroids in High-Cell-Density Suspension Perfusion Culture: In Vitro Performance in Synthesized Culture Medium and in 100% Human Plasma
title_sort new bioartificial liver using porcine hepatocyte spheroids in high-cell-density suspension perfusion culture: in vitro performance in synthesized culture medium and in 100% human plasma
publisher SAGE Publishing
series Cell Transplantation
issn 0963-6897
1555-3892
publishDate 1999-09-01
description A prototype of a bioartificial liver (BAL) based on suspension perfusion culture of porcine hepatocyte spheroids was developed at 150 ml scale. About 2% (4 × 10 9 cells) of whole human liver cells was immobilized. The cell density in the bioreactor was 2.7 × 10 7 cells/ml, which was almost comparable to that of presently developed packed-bed-type BALs. The bioreactor was perfused with culture medium while retaining spheroids. This was done using a rotating stainless filter (pore size 50 μm). In vitro 8-h perfusion experiments utilizing both synthesized culture medium and 100% human plasma demonstrated the spheroids in the bioreactor had almost the same functions on a unit/cell basis as those in small-scale rotational culture. This indicated that the functional deterioration often associated with scaling up had been minimized. Rapid spheroid aggregation and dysfunction in specific human plasma pool must be eliminated before clinical application, although this phenomenon seemed to be inherent to porcine hepatocyte-based BALs. This prototype shows promise in meeting present clinical demands by achieving maximal metabolic activities even in the short term.
url https://doi.org/10.1177/096368979900800508
work_keys_str_mv AT yasuyukisakai anewbioartificialliverusingporcinehepatocytespheroidsinhighcelldensitysuspensionperfusioncultureinvitroperformanceinsynthesizedculturemediumandin100humanplasma
AT katsutoshinaruse anewbioartificialliverusingporcinehepatocytespheroidsinhighcelldensitysuspensionperfusioncultureinvitroperformanceinsynthesizedculturemediumandin100humanplasma
AT ikuonagashima anewbioartificialliverusingporcinehepatocytespheroidsinhighcelldensitysuspensionperfusioncultureinvitroperformanceinsynthesizedculturemediumandin100humanplasma
AT tetsuichiromuto anewbioartificialliverusingporcinehepatocytespheroidsinhighcelldensitysuspensionperfusioncultureinvitroperformanceinsynthesizedculturemediumandin100humanplasma
AT motoyukisuzuki anewbioartificialliverusingporcinehepatocytespheroidsinhighcelldensitysuspensionperfusioncultureinvitroperformanceinsynthesizedculturemediumandin100humanplasma
AT yasuyukisakai newbioartificialliverusingporcinehepatocytespheroidsinhighcelldensitysuspensionperfusioncultureinvitroperformanceinsynthesizedculturemediumandin100humanplasma
AT katsutoshinaruse newbioartificialliverusingporcinehepatocytespheroidsinhighcelldensitysuspensionperfusioncultureinvitroperformanceinsynthesizedculturemediumandin100humanplasma
AT ikuonagashima newbioartificialliverusingporcinehepatocytespheroidsinhighcelldensitysuspensionperfusioncultureinvitroperformanceinsynthesizedculturemediumandin100humanplasma
AT tetsuichiromuto newbioartificialliverusingporcinehepatocytespheroidsinhighcelldensitysuspensionperfusioncultureinvitroperformanceinsynthesizedculturemediumandin100humanplasma
AT motoyukisuzuki newbioartificialliverusingporcinehepatocytespheroidsinhighcelldensitysuspensionperfusioncultureinvitroperformanceinsynthesizedculturemediumandin100humanplasma
_version_ 1724568968851619840